TD Cowen Reiterates Buy Rating on GoodRx Holdings Inc. (GDRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
GoodRx Holdings Inc. (GDRX) PT Lowered to $8 at Deutsche Bank
May 13, 2024 5:49 AM EDTDeutsche Bank analyst George Hill lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $8.00 (from $9.00) while maintaining a Hold rating.
The analyst comments "Modest Q1 Beat With Continued Margin Expansion: GDRX reported solid Q1 results with modest revenue beat and better-than-expected... More
GoodRx Holdings, Inc. (GDRX) Tops Q1 EPS by 1c ; Offers Guidance
May 9, 2024 6:15 AM EDTGoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $197.9 million versus the consensus estimate of $196.09 million.
GUIDANCE:
GoodRx Holdings, Inc. sees Q2 2024 revenue of $200 million, versus the... More
